Neurodermatitis
Conditions
Brief summary
The purpose of this study is to evaluate the therapeutic effect of shockwave therapy on reducing pruritus in neurodermatitis patients.
Detailed description
Based on the occurrence of side effects caused by conventional medication for prolonged employment, dermatologists and patients show solicitude for multifaceted effective methods to control the chronic and relapsing nature of neurodermatitis. Although new modalities are continuously coming up for pruritus, there remains a great gap for providing symptom relief. Furthermore, there is a lack in the quantitative knowledge and information in the published studies about benefits of shockwave therapy on the treatment of pruritus in neurodermatitis patients. So, this study is designed to outline the therapeutic efficacy of shockwave therapy on the treatment of pruritus in neurodermatitis patients.
Interventions
DEVICEShockwave therapy
The procedures for Extracorporeal Shockwave Therapy (ESWT) involve several steps. First, the patient is positioned comfortably, and the physiotherapist explains the treatment procedure. Before the session begins, the device cables are checked for proper functioning. The shockwave type used is Non-Focused/Radial, with a treatment duration not exceeding 10 minutes. The frequency is set at 4 Hz, and the intensity ranges from 0.05 to 0.20 mJ/mm². Each session involves a total of 1000 to 2000 shocks. The treatment consists of four sessions, each held once a week.
DRUGEmollients & corticosteroids
Patients in both groups will receive emollients \& corticosteroids for one month.
Sponsors
Cairo University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
55 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* Age range between 55:75 years. * Male and female patients will participate in the study. * All patients have neurodermatitis. * All patients will be received the same approach of medication and nursing care. * All patients enrolled in the study will have their informed consent.
Exclusion criteria
* Patients diagnosed with cancer. * Pregnant woman. * active infection. * Patients with any systemic diseases that may interfere with the objectives of the study. * Cardiac pacemakers or other implantable devices. * Current anticoagulation use. * Any other cause of itching
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 5-D Itching Scale | one month | The 5-D Itching Scale will be used to assess the improvement of cases by evaluating pruritus severity. Patients will complete the scale both before starting the treatment and at four sessions following the treatment. The following steps will be followed during the assessment: the patient will be positioned comfortably (sitting position), the physiotherapist will explain the pruritus symptoms score to the patient, and the patient will determine their points on the 5-D itch scale. |
Countries
Egypt
Contacts
STUDY_CHAIRNessrien Afify Abd El Rashid, PhD
Assistant Professor, Cairo University
STUDY_DIRECTORNoha Zakaria Tawfik, PhD
Assistant Professor, Suez Canal University
STUDY_DIRECTORDoaa Atef Aly, PhD
Lecturer, Cairo university
Outcome results
None listed